AVEANNA HEALTHCARE HOLDINGS
AVAHNASDAQTrading Snapshot
- Day Range
- $12.73 β $12.93
- 52-Week Range
- $5.93 β $14.71
- Volume
- $2.82B
- Avg Volume
- $3.38B
- Shares Outstanding
- 217.8M
- Next Earnings
- Dec 4, 2026
Fundamentals Snapshot
- Annual Revenue
- $2.43B
- Last Q Revenue
- $670M
- P/E Ratio
- 9.6
- P/S Ratio
- 1.1x
- EPS (TTM)
- $1.26
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +1.2%
Why Investors Own AVAH
- βHigh-growth profile β revenue up -5.4% YoY with expanding US Equity exposure.
- βHealthy economics β 37% gross margin and 28% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
AVEANNA HEALTHCARE HOLDINGS
AVAHAbout AVEANNA HEALTHCARE HOLDINGS
Aveanna Healthcare Holdings Inc. operates as a diverse platform for home-based care services throughout the United States. The company delivers a range of critical offerings, including private duty nursing (PDN), adult home health and hospice care, in-home pediatric therapy, and enteral nutrition services. Its patient-centered approach allows individuals to receive essential medical care within their own homes, effectively reducing the need for costly institutional settings such as hospitals. The company's operations are structured into three key segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment provides specialized private duty nursing, which includes skilled nursing care for medically fragile children at home, nursing support in school environments, and services at pediatric day healthcare centers. This segment also offers employer-of-record support, personal care services, and pediatric therapy (physical, occupational, and speech) provided both in clinics and patients' residences. The HHH segment focuses on home health services, encompassing in-home skilled nursing, physical, occupational, and speech therapy, as well as medical social work and aide assistance. Furthermore, it delivers hospice services, offering compassionate care to patients and their families when life-limiting illnesses no longer respond to curative treatments. The MS segment supplies enteral nutrition products and other vital medical supplies to adults and children, distributed on either a scheduled or as-needed basis. Founded in 2016, Aveanna Healthcare Holdings Inc. is headquartered in Atlanta, Georgia.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Price Target
βLatest News & Updates

Are Investors Undervaluing Aveanna Healthcare (AVAH) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and

5 Top-Ranked Stocks Likely to Deliver Earnings Beats
Top-ranked stocks AVAH, FTNT, THC, ARW and VLO are likely to beat on the bottom line in their upcoming releases.

Here's Why Aveanna Healthcare (AVAH) is a Great Momentum Stock to Buy
Does Aveanna Healthcare (AVAH) have what it takes to be a top stock pick for momentum investors? Let's find out.

Aveanna Healthcare Holdings Inc. (AVAH) Presents at Deutsche Bank 2026 Healthcare Summit Transcript
Aveanna Healthcare Holdings Inc. (AVAH) Presents at Deutsche Bank 2026 Healthcare Summit Transcript

Aveanna Healthcare Holdings Inc. (AVAH) Hits Fresh High: Is There Still Room to Run?
Aveanna (AVAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Hsbc Holdings PLC Takes Position in Aveanna Healthcare Holdings Inc. $AVAH
Hsbc Holdings PLC acquired a new position in shares of Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchang